Tema Oncology ETF (NASDAQ:CANC) Trading 0.4% Higher – Should You Buy?

Shares of Tema Oncology ETF (NASDAQ:CANC) were up 0.4% on Thursday . The stock traded as high as $36.28 and last traded at $36.09. Approximately 116,268 shares were traded during trading, an increase of 86% from the average daily volume of 62,393 shares. The stock had previously closed at $35.93.

Tema Oncology ETF Trading Up 0.4%

The stock has a 50 day simple moving average of $35.49 and a 200 day simple moving average of $30.84. The firm has a market capitalization of $142.92 million, a PE ratio of 20.39 and a beta of 1.00.

Tema Oncology ETF Announces Dividend

The company also recently announced an annual dividend, which was paid on Thursday, December 11th. Investors of record on Wednesday, December 10th were paid a $0.0196 dividend. This represents a dividend yield of 6.0%. The ex-dividend date of this dividend was Wednesday, December 10th.

Institutional Investors Weigh In On Tema Oncology ETF

A number of large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC purchased a new position in shares of Tema Oncology ETF in the first quarter valued at about $213,000. Flow Traders U.S. LLC bought a new stake in shares of Tema Oncology ETF in the third quarter worth about $630,000. Finally, Thrivent Financial for Lutherans increased its holdings in Tema Oncology ETF by 658.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 957,475 shares of the company’s stock valued at $23,673,000 after purchasing an additional 831,281 shares during the period.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.